This technology, offered for licensing, provides a novel and potentially non-toxic approach to treat a wide range of cancers using RNA Inhibitors.
Available for Licensing or Sale. Developed by a doctor with extensive experience in treating patients with eczema, psoriasis, and dry, itchy or infected skin.
These biocompatible, non-toxic nanospheres are 20-80 nm in size and due to their hydrophilc-hydrophobic nature, are ideally suited for encapsulating drugs.
These are novel therapeutic agents/compounds for the treatment of sepsis, and work by binding to the endotoxins released by the bacteria.